Materiales de Congresos

Buscador de Información Médica
Argentina
 

Para poder brindarle contenido relevante y significativo, necesitamos saber más sobre usted.

Elija la categoría que mejor le describa.

This content is intended for Healthcare professionals in República Argentina. Would you like to proceed?

Soy un profesional de la salud de la República ArgentinaYes, I am a healthcare professional
SeleccionarSoy un profesional de la salud de la República ArgentinaYes, I am a healthcare professional
Soy un paciente o cuidadorNo, volver al sitio para pacientes
SeleccionarSoy un paciente o cuidadorNo, volver al sitio para pacientes
Para residentes fuera de Argentina haga click aquí.

Materiales de Congresos

La información de esta página es seleccionada de materiales de congresos, áreas terapéuticas y de enfermedades. No pretende servir como una descripción general completa de todos los contenidos mencionados
Póster
Lee CA, Ramaiya A, Tang Y, Sapone A, Gilder K, Randle A, Grundy JS Octubre 11, 2022 UEGW 2022 Colitis Ulcerativa

A Phase 1 Drug Interaction Study Evaluating the Effects of Itraconazole on the Pharmacokinetics, Safety, and Tolerability of Etrasimod in Healthy Volunteers

Ver Presentación
Póster
Danese S, Komori HK, Ryan RD, Cataldi F, Lee CA, Goetsch M, Siegmund B Octubre 11, 2022 UEGW 2022 Colitis Ulcerativa

Effect of Etrasimod on Circulating Lymphocytes in Patients With Moderately to Severely Active Ulcerative Colitis: Data From the Phase 3 ELEVATE UC 52 and ELEVATE UC 12 Trials

Ver Presentación
Póster
Feagan BG, * Peyrin-Biroulet L, * Sandborn WJ, D’Haens G, Panés J, Yarur A, Wolf DC, Ritter T, Schreiber S, Sloan S, Cataldi F, Shan K, Rabbat CJ, Chiorean M, Baert F, Sands BE, Dubinsky MC, Vermeire S, Goetsch M, Danese S. Octubre 11, 2022 UEGW 2022 Colitis Ulcerativa

Etrasimod 2 mg Once Daily as Treatment for Biologic/Janus Kinas Inhibitor-Naive and -Experienced Patients with Moderately to Severely Active Ulcerative Colitis: Subgroup Analysis From the Phase 3 ELEVATE UC 52 and ELEVATE UC 12 Trials

Ver Presentación
Presentación Oral
Sandborn WJ*, Vermiere S*, Peyrin-Biroulet L, Dubinsky MC, Panés J, Yarur A, Ritter T, Baert F, Schreiber S, Sloan S, Cataldi F, Shan K, Rabbat CJ, Chiorean M, Wolf DC, Sands BE, D’Haens G, Danese S, Goetsch M, Feagan BG *Co first authors. Octubre 11, 2022 UEGW 2022 Colitis Ulcerativa

Etrasimod 2 mg Once Daily as Treatment for Moderately to Severely Active Ulcerative Colotis: Results from the Phase 3 ELEVATE UC 52 and ELEVATE UC 12 Trials

Ver Presentación
Póster
Schreiber S, Rubin DT, Ng SC, Modesto I, Guo X, Su C, Kwok KK, Jo H, Chen Y, Yndestad A, Reinisch W, Dubinsky MC Octubre 11, 2022 UEGW 2022 Colitis Ulcerativa

Major adverse cardiovascular events by baseline cardiovascular risk stratification in patients with ulcerative colitis treated with tofacitinib: data from the OCTAVE clinical programme

Ver Presentación
Póster
Lee CA, Waterhouse T, Heathman M, Oh DA, Komori HK, Grundy JS Octubre 11, 2022 UEGW 2022 Colitis Ulcerativa

Model-Predicted Lymphocyte Response and Recovery Profiles for the Sphingosine 1-Phosphate Receptor Modulators Ozanimod and Etrasimod

Ver Presentación
Póster
Lee CA, Tang Y, Villa-Caballero L, Shan K, Randle A, Grundy JS Octubre 11, 2022 UEGW 2022 Colitis Ulcerativa

Pharmacokinetics, Safety, and Tolerability of Etrasimod: Results From a Phase 1 Drug-Drug Interaction Study in Healthy Volunteers

Ver Presentación
Póster
Rubin DT, Salese L, Kotze PG, Woolcott JC, Su C, Mundayat R, Paulissen J, Torres J, Long MD Pfizer owner: Cohen M Octubre 11, 2022 UEGW 2022 Colitis Ulcerativa

Presence of risk factors associated with colectomy among patients with colectomy in the tofacitinib OCTAVE ulcerative colitis clinical programme

Ver Presentación
Póster
Targownik L, Dubinsky MC, Steinwurz F, Bushmakin AG, Cappelleri JC, Tai E, Gardiner S, Hur P, Panés J Octubre 11, 2022 UEGW 2022 Colitis Ulcerativa

Relationship between disease activity as assessed by the Mayo score and work productivity in patients with ulcerative colitis in the tofacitinib OCTAVE Phase 3 induction and maintenance studies

Ver Presentación
Póster
Targownik L, Dubinsky MC, Steinwurz F, Bushmakin AG, Cappelleri JC, Tai E, Gardiner S, Hur P, Panés J Octubre 11, 2022 UEGW 2022 Colitis Ulcerativa

Relationship between health-related quality of life and work productivity in patients with ulcerative colitis in the tofacitinib OCTAVE Phase 3 induction and maintenance studies

Ver Presentación